204 related articles for article (PubMed ID: 33606344)
1. Radioimmunotherapy with an
Takashima H; Koga Y; Manabe S; Ohnuki K; Tsumura R; Anzai T; Iwata N; Wang Y; Yokokita T; Komori Y; Mori D; Usuda S; Haba H; Fujii H; Matsumura Y; Yasunaga M
Cancer Sci; 2021 May; 112(5):1975-1986. PubMed ID: 33606344
[TBL] [Abstract][Full Text] [Related]
2. Tumor Targeting of
Takashima H; Ohnuki K; Manabe S; Koga Y; Tsumura R; Anzai T; Wang Y; Yin X; Sato N; Shigekawa Y; Nambu A; Usuda S; Haba H; Fujii H; Yasunaga M
Mol Pharm; 2023 Feb; 20(2):1156-1167. PubMed ID: 36573995
[TBL] [Abstract][Full Text] [Related]
3. Utility of epirubicin-incorporating micelles tagged with anti-tissue factor antibody clone with no anticoagulant effect.
Sugaya A; Hyodo I; Koga Y; Yamamoto Y; Takashima H; Sato R; Tsumura R; Furuya F; Yasunaga M; Harada M; Tanaka R; Matsumura Y
Cancer Sci; 2016 Mar; 107(3):335-40. PubMed ID: 26676840
[TBL] [Abstract][Full Text] [Related]
4. Antitumor effect of antitissue factor antibody-MMAE conjugate in human pancreatic tumor xenografts.
Koga Y; Manabe S; Aihara Y; Sato R; Tsumura R; Iwafuji H; Furuya F; Fuchigami H; Fujiwara Y; Hisada Y; Yamamoto Y; Yasunaga M; Matsumura Y
Int J Cancer; 2015 Sep; 137(6):1457-66. PubMed ID: 25704403
[TBL] [Abstract][Full Text] [Related]
5. Astatine-211 conjugated to an anti-CD20 monoclonal antibody eradicates disseminated B-cell lymphoma in a mouse model.
Green DJ; Shadman M; Jones JC; Frayo SL; Kenoyer AL; Hylarides MD; Hamlin DK; Wilbur DS; Balkan ER; Lin Y; Miller BW; Frost SH; Gopal AK; Orozco JJ; Gooley TA; Laird KL; Till BG; Bäck T; Sandmaier BM; Pagel JM; Press OW
Blood; 2015 Mar; 125(13):2111-9. PubMed ID: 25628467
[TBL] [Abstract][Full Text] [Related]
6. Direct procedure for the production of 211At-labeled antibodies with an epsilon-lysyl-3-(trimethylstannyl)benzamide immunoconjugate.
Lindegren S; Frost S; Bäck T; Haglund E; Elgqvist J; Jensen H
J Nucl Med; 2008 Sep; 49(9):1537-45. PubMed ID: 18703591
[TBL] [Abstract][Full Text] [Related]
7. Near-infrared photoimmunotherapy of pancreatic cancer using an indocyanine green-labeled anti-tissue factor antibody.
Aung W; Tsuji AB; Sugyo A; Takashima H; Yasunaga M; Matsumura Y; Higashi T
World J Gastroenterol; 2018 Dec; 24(48):5491-5504. PubMed ID: 30622378
[TBL] [Abstract][Full Text] [Related]
8. Labeling of Anti-HER2 Nanobodies with Astatine-211: Optimization and the Effect of Different Coupling Reagents on Their in Vivo Behavior.
Dekempeneer Y; Bäck T; Aneheim E; Jensen H; Puttemans J; Xavier C; Keyaerts M; Palm S; Albertsson P; Lahoutte T; Caveliers V; Lindegren S; D'Huyvetter M
Mol Pharm; 2019 Aug; 16(8):3524-3533. PubMed ID: 31268724
[TBL] [Abstract][Full Text] [Related]
9. Effectiveness and normal tissue toxicity of Auger electron (AE) radioimmunotherapy (RIT) with [
Chan C; Fonge H; Lam K; Reilly RM
Nucl Med Biol; 2020; 80-81():37-44. PubMed ID: 31706737
[TBL] [Abstract][Full Text] [Related]
10. Enhanced antitumor effect of anti-tissue factor antibody-conjugated epirubicin-incorporating micelles in xenograft models.
Yamamoto Y; Hyodo I; Koga Y; Tsumura R; Sato R; Obonai T; Fuchigami H; Furuya F; Yasunaga M; Harada M; Kato Y; Ohtsu A; Matsumura Y
Cancer Sci; 2015 May; 106(5):627-34. PubMed ID: 25711681
[TBL] [Abstract][Full Text] [Related]
11. Antitumor effect of humanized anti‑tissue factor antibody‑drug conjugate in a model of peritoneal disseminated pancreatic cancer.
Tsumura R; Anzai T; Manabe S; Takashima H; Koga Y; Yasunaga M; Matsumura Y
Oncol Rep; 2021 Jan; 45(1):329-336. PubMed ID: 33200231
[TBL] [Abstract][Full Text] [Related]
12. Molecular imaging using an anti-human tissue factor monoclonal antibody in an orthotopic glioma xenograft model.
Takashima H; Tsuji AB; Saga T; Yasunaga M; Koga Y; Kuroda JI; Yano S; Kuratsu JI; Matsumura Y
Sci Rep; 2017 Sep; 7(1):12341. PubMed ID: 28951589
[TBL] [Abstract][Full Text] [Related]
13. Vascular-targeted radioimmunotherapy with the alpha-particle emitter 211At.
Kennel SJ; Mirzadeh S; Eckelman WC; Waldmann TA; Garmestani K; Yordanov AT; Stabin MG; Brechbiel MW
Radiat Res; 2002 Jun; 157(6):633-41. PubMed ID: 12005541
[TBL] [Abstract][Full Text] [Related]
14. α-particle therapy for synovial sarcoma in the mouse using an astatine-211-labeled antibody against frizzled homolog 10.
Li HK; Sugyo A; Tsuji AB; Morokoshi Y; Minegishi K; Nagatsu K; Kanda H; Harada Y; Nagayama S; Katagiri T; Nakamura Y; Higashi T; Hasegawa S
Cancer Sci; 2018 Jul; 109(7):2302-2309. PubMed ID: 29952132
[TBL] [Abstract][Full Text] [Related]
15. 211At radioimmunotherapy of subcutaneous human ovarian cancer xenografts: evaluation of relative biologic effectiveness of an alpha-emitter in vivo.
Bäck T; Andersson H; Divgi CR; Hultborn R; Jensen H; Lindegren S; Palm S; Jacobsson L
J Nucl Med; 2005 Dec; 46(12):2061-7. PubMed ID: 16330571
[TBL] [Abstract][Full Text] [Related]
16. Sacituzumab Govitecan (IMMU-132), an Anti-Trop-2/SN-38 Antibody-Drug Conjugate: Characterization and Efficacy in Pancreatic, Gastric, and Other Cancers.
Cardillo TM; Govindan SV; Sharkey RM; Trisal P; Arrojo R; Liu D; Rossi EA; Chang CH; Goldenberg DM
Bioconjug Chem; 2015 May; 26(5):919-31. PubMed ID: 25915780
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the antitumor mechanism of antibody-drug conjugates against tissue factor in stroma-rich allograft models.
Tsumura R; Manabe S; Takashima H; Koga Y; Yasunaga M; Matsumura Y
Cancer Sci; 2019 Oct; 110(10):3296-3305. PubMed ID: 31348600
[TBL] [Abstract][Full Text] [Related]
18. Astatine-211-labeled antibodies for treatment of disseminated ovarian cancer: an overview of results in an ovarian tumor model.
Andersson H; Elgqvist J; Horvath G; Hultborn R; Jacobsson L; Jensen H; Karlsson B; Lindegren S; Palm S
Clin Cancer Res; 2003 Sep; 9(10 Pt 2):3914S-21S. PubMed ID: 14506189
[TBL] [Abstract][Full Text] [Related]
19. Treating Tissue Factor-Positive Cancers with Antibody-Drug Conjugates That Do Not Affect Blood Clotting.
Theunissen JW; Cai AG; Bhatti MM; Cooper AB; Avery AD; Dorfman R; Guelman S; Levashova Z; Migone TS
Mol Cancer Ther; 2018 Nov; 17(11):2412-2426. PubMed ID: 30126944
[TBL] [Abstract][Full Text] [Related]
20. An antibody-drug conjugate that targets tissue factor exhibits potent therapeutic activity against a broad range of solid tumors.
Breij EC; de Goeij BE; Verploegen S; Schuurhuis DH; Amirkhosravi A; Francis J; Miller VB; Houtkamp M; Bleeker WK; Satijn D; Parren PW
Cancer Res; 2014 Feb; 74(4):1214-26. PubMed ID: 24371232
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
